Drug Profile
NS5B primer grip inhibitor - Bristol-Myers Squibb
Latest Information Update: 14 Nov 2013
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 07 Nov 2013 Discontinued for Hepatitis C in USA (unspecified route)
- 31 Dec 2011 Investigation in Hepatitis C in USA (unspecified route)